TNF and neoplasm: Specifically, the mice exposed to both FMT acceptability for donation and immunotherapy with anti-PD1 demonstrated a 2.5-fold increase in IFN-γ levels and a 1.8-fold increase in TNF-α within the tumor microenvironment when compared to controls, reflecting a higher systemic anti-tumor immunity [19].